Doxil (doxorubicin HCl liposome injection)
Published: Oct 15, 2008 8:00 am
| Brand Name: | Doxil | |
| Generic Name: | doxorubicin HCl liposome injection | |
| Code Name: | ||
| Company: | Ortho Biotech | |
| FDA Clinical Phase: | 3 |
Description:
A form of the anticancer drug doxorubicin that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than doxorubicin. Doxil is used to treat ovarian cancer, AIDS-related Kaposi sarcoma, and multiple myeloma in patients whose disease has not gotten better after treatment with other anticancer drugs. It may be used together with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Doxil is a type of anthracycline antitumor antibiotic.
Clinical Trials:
Currently, there are many open clinical studies involving Doxil.
Official website for Doxil: http://www.doxil.com/
Source: NCI Cancer Glossary, Doxil, http://www.cancer.gov/templates/db_alpha.aspx?searchTxt=doxil (as of September 4, 2008)
Related Articles:
- Velcade-Doxil-Dexamethasone Combination Is Effective And Safe In Elderly Myeloma Patients
- Velcade-Doxil-Dexamethasone Combination Treatment Is Highly Effective In Newly Diagnosed Multiple Myeloma Patients
- New Directory Could Assist In Myeloma Treatment
- Phase 2 Clinical Trial Offers Positive Results For A Steroid-Free Multiple Myeloma Treatment
- Guide To Clinical Trials For Multiple Myeloma Patients – Part 2: Benefits And Risks Of Clinical Trials
Leave a comment